ETF Building Blocks ChannelSBIO Is a Good Place to Be for Biotech InnovationBy Tom LydonFebruary 28, 2022
ETF Building Blocks ChannelConsolidation Could Come Calling for Biotech in 2022By Tom LydonJanuary 5, 2022
ETF Building Blocks ChannelMemeification of Biotech Stocks Shines Light on This ETFBy Tom LydonNovember 24, 2021
ETF Building Blocks ChannelBiotech Ready to Participate in Healthcare BullishnessBy Tom LydonOctober 29, 2021
ETF Building Blocks ChannelDrug Price Debate May Not Hinder Biotech ETFs After AllBy Tom LydonSeptember 16, 2021
ETF Building Blocks ChannelBiotech Stocks Have Colds, but They Can HealBy Tom LydonSeptember 13, 2021
ETF Building Blocks ChannelWill the Biotech Space Consolidate in the Back Half of the Year?By Tom LydonJuly 14, 2021
ETF Building Blocks ChannelPost-Pandemic Healthcare Could Feature More Biotech M&ABy Tom LydonJune 10, 2021
ETF Building Blocks ChannelAs Biotech Consolidation Heats up, ‘SBIO’ Could Be a WinnerBy Tom LydonMay 24, 2021
